1. Home
  2. PHAR vs ODC Comparison

PHAR vs ODC Comparison

Compare PHAR & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$18.12

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Oil-Dri Corporation Of America

ODC

Oil-Dri Corporation Of America

HOLD

Current Price

$49.38

Market Cap

790.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHAR
ODC
Founded
1988
1941
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
790.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PHAR
ODC
Price
$18.12
$49.38
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$38.00
N/A
AVG Volume (30 Days)
24.0K
87.9K
Earning Date
11-06-2025
12-08-2025
Dividend Yield
N/A
1.65%
EPS Growth
N/A
17.33
EPS
0.00
3.63
Revenue
$362,274,000.00
$478,113,000.00
Revenue This Year
$25.19
N/A
Revenue Next Year
$4.47
N/A
P/E Ratio
$3,041.40
$13.69
Revenue Growth
26.78
5.29
52 Week Low
$7.50
$40.66
52 Week High
$18.12
$69.76

Technical Indicators

Market Signals
Indicator
PHAR
ODC
Relative Strength Index (RSI) 58.10 38.14
Support Level $16.98 $45.61
Resistance Level $17.00 $54.16
Average True Range (ATR) 0.69 2.23
MACD 0.03 -0.01
Stochastic Oscillator 82.04 42.48

Price Performance

Historical Comparison
PHAR
ODC

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

Share on Social Networks: